Erratum: The stabilizing effect of moisture on the solid-state degradation of gabapentin (AAPS PharmSciTech DOI: 10.1208/s12249-011-9652-8);The stabilizing effect of moisture on the solid-state degradation of gabapentin

AAPS PharmSciTech

Volumn 12, Issue 3, 2011, Pages 924-931

  Zong, Zhixin ^a   Desai, Salil D ^a   Kaushal, Aditya M ^b   Barich, Dewey H ^c   Huang, Hong Shian ^a   Munson, Eric J ^d   Suryanarayanan, Raj ^b   Kirsch, Lee E ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

drug degradation kinetics; gabapentin; lactamization; moisture effect; solid state stability

Indexed keywords

GABAPENTIN; LACTAM;

ARTICLE; ATMOSPHERIC MOISTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYCLIZATION; DRUG DEGRADATION; DRUG STABILITY; HUMIDITY; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID STATE; SURFACE PROPERTY; X RAY DIFFRACTION;

EID: 80052590367     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9692-0     Document Type: Erratum

References (24)

1. JA Ibers 2001 Gabapentin and gabapentin monohydrate Acta Crystallogr, Section C: Cryst Struct Commun C57 641 3 10.1107/S0108270101003341 1:CAS:528:DC%2BD3MXjsVGisbo%3D (Pubitemid 32471480)
2. Pesachovich M, Singer C, Pilarski G. Preparation of gabapentin. WO98/28255, 25 pp. 1998
3. HA Reece DC Levendis 2008 Polymorphs of gabapentin Acta Crystallogr, Section C: Cryst Struct Commun C64 3 o105 8 10.1107/S0108270107066279 1:CAS:528:DC%2BD1cXislKis74%3D (Pubitemid 351346905)
4. AS Kearney SC Mehta GW Radebaugh 1992 The effect of cyclodextrins on the rate of intramolecular lactamization of gabapentin in aqueous solution Int J Pharm 78 1 25 34 10.1016/0378-5173(92)90351-2 1:CAS:528:DyaK38XptFagsA%3D%3D
5. CH Hsu WT Ke SY Lin 2010 Progressive steps of polymorphic transformation of gabapentin polymorphs studied by hot-stage FTIR microspectroscopy J Pharm Pharmaceut Sci 13 67 77 1:CAS:528:DC%2BC3cXkvVKjsL4%3D
6. D Brago F Grepioni L Maini K Rubini M Polito R Brescello, et al. 2008 Polymorphic gabapentin: thermal behavior, reactivity and interconversion of form in solution and solid-state New J Chem 32 1788 95 10.1039/b809662g
7. SY Lin CH Hsu W Ke 2010 Solid-state transformation of different gabapentin polymorphs upon milling and co-milling Int J Pharm 396 83 90 20561572 10.1016/j.ijpharm.2010.06.014 1:CAS:528:DC%2BC3cXpt1Squr0%3D
8. E Zour SA Lodhi GW Radebaugh 1992 Stability studies of gabapentin in aqueous solutions Pharm Res 9 5 595 600 1608888 10.1023/A:1015833622943 1:CAS:528:DyaK38XktlemsLo%3D
9. E Zambon R Giovanetti L Cotarca L Pasquato 2008 Mechanistic investigation on 2-aza-spiro[4,5]decan-3-one formation from 1-(aminomethyl)cyclohexylacetic acid (gabapentin) Tetrahedron 64 28 6739 43 10.1016/j.tet.2008.05.010 1:CAS:528:DC%2BD1cXnt1KqtLY%3D
10. A Cutrignelli N Denora A Lepedota A Trapani V Laquintana A Latrofa, et al. 2007 Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations Int J Pharm 332 1-2 98 106 17071027 10.1016/j.ijpharm.2006.09.053 1:CAS:528: DC%2BD2sXhvVSktro%3D (Pubitemid 46227771)
11. Chawla M, Raghuvanshi R, Rampal A. Sustained release oral tablets of gabapentin and process for their preparation. WO 2005/020978 A1, 23 pp. 2005
12. Augart H, Gebhardt U, Herrmann W. Lactam-free amino acids. US 6,054,482, 5 pp. 2000
13. Singer C, Pilarski F, Pesachovich M. Stable gabapentin containing more than 20 ppm of chlorine ion. WO 01/97612 A1, 24 pp. 2001
14. Manikandan R, Gogia A, Roy S, Makik R. Gabapentin tablets and methods for their preparation. WO 2004/032905 A1, 17 pp. 2004
15. Sherman B. Solid compositions comprising gabapentin having improved stability. WO 2004/014356, 10 pp. 2004
16. Chawla M, Raghuvanshi R, Rampla A. Stable sustained-release oral dosage forms of gabapentin and process for preparation thereof. WO 2005/077332 A2, 20 pp. 2005
17. Yande V, Kulkarni S, Narasimharaghavan S, Meenakshisunderam S. Stable liquid formulation of antiepileptic agents. WO 2007/107835 A2, 9 pp. 2007
18. Lloret P. Solid pharmaceutical composition of gabapentin. WO 2007/128495, 25 pp. 2007
19. DA Volpe A Gupta AB Ciavarella PJ Faustino VA Sayeed MA Khan 2008 Comparison of the stability of split and intact gabapentin tablets Int J Pharm 350 1-2 65 9 17935918 10.1016/j.ijpharm.2007.08.041 1:CAS:528: DC%2BD1cXhtlGmsr4%3D
20. A Gupta AB Ciavarella VA Sayeed MA Khan PJ Faustino 2008 Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products J Pharm Biomed Anal 46 1 181 6 17935923 10.1016/j.jpba.2007.08.023 1:CAS:528:DC%2BD2sXhsVWjtrzF (Pubitemid 350216326)
21. Steiner K, Herrmann W, Baumagarten Z, Crone G. Process for the preparation of cyclic amino acids and intermediates useful in the process. US 5068413, 8 pp. 1991
22. EL Inman HJ Tenbarge 1988 High-low chromatography: estimating impurities in HPLC using a pair of sample injections J Chromatogr Sci 26 89 94 1:CAS:528:DyaL1cXitFGmt7c%3D
23. Geibel W, Hartenstein J, Herrmann W, Witzke J. Process for the preparation of 1-aminomethyl-1-cyclohexaneacetic acid. US 5091567, 12 pp. 1992
24. Bryans J, Morrell A. Novel stereoselective processes for the preparation of gabapentin analogues. WO 9914184, 19 pp. 1999